SpringerLink
Log in

Bacillus Calmette-Guerin (BCG) Vaccine Impact on Dementia Risk in Bladder Cancer Patients: A Systematic Review and Meta-Analysis

  • Original Research
  • Published:
The Journal of Prevention of Alzheimer's Disease Aims and scope Submit manuscript

Abstract

Background

The BCG vaccine has been traditionally administered to prevent TB. It has been additionally used in bladder cancer patients as a therapy with success. Some observational studies found that bladder cancer patients receiving BCG may have reduced dementia risk, however, the evidence is not conclusive.

Objective

To investigate the impact of BCG vaccine on dementia risk in bladder cancer patients.

Methods

Six databases were searched from inception to January 13, 2024, for published and unpublished studies that examine the association between BCG and dementia risk in bladder cancer patients. We conducted meta-analyses using a random-effects model.

Results

Eight retrospective cohort studies were included in the systematic review and seven in the meta-analyses. Because there were studies with overlap** populations, two separate main analyses were performed reassuring the avoidance of overlap. The first analysis showed that compared to controls, BCG did not reduce dementia risk [5 studies pooled, n=88,852, HR = 0.65, 95% CI (0.40, 1.06), I2 = 85%] whereas there was a marginally significant risk reduction in the second analysis [6 studies pooled, n=70,025, HR = 0.63, 95% CI (0.40, 0.97), I2 = 83%]. Sensitivity analysis excluding the unpublished studies did not affect the outcome importantly. Additional meta-analysis showed that BCG did not reduce the risk of Alzheimer’s disease.

Conclusion

This meta-analysis of observational studies found that BCG administration in bladder cancer patients has likely a minimally positive impact on dementia risk if any. To better understand the effect of BCG on dementia, randomized controlled trials are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. The Lancet Public Health. 2022;7:e105–e125. DOI: https://doi.org/10.1016/S2468-2667(21)00249-8

    Article  Google Scholar 

  2. Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and Management of Dementia: Review. JAMA. 2019;322:1589. DOI: https://doi.org/10.1001/jama.2019.4782

    Article  PubMed  PubMed Central  Google Scholar 

  3. Magrath Guimet N, Zapata-Restrepo LM, Miller BL. Advances in Treatment of Frontotemporal Dementia. J Neuropsychiatry Clin Neurosci. 2022;34:316–327. DOI: https://doi.org/10.1176/appi.neuropsych.21060166

    Article  PubMed  Google Scholar 

  4. Taylor J-P, McKeith IG, Burn DJ, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19:157–169. DOI: https://doi.org/10.1016/S1474-4422(19)30153-X

    Article  PubMed  Google Scholar 

  5. Iadecola C, Duering M, Hachinski V, et al. Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73:3326–3344. DOI: https://doi.org/10.1016/j.jacc.2019.04.034

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kwon S, Iba M, Kim C, Masliah E. Immunotherapies for Aging-Related Neurodegenerative Diseases-Emerging Perspectives and New Targets. Neurotherapeutics. 2020;17:935–954. DOI: https://doi.org/10.1007/s13311-020-00853-2

    Article  PubMed  PubMed Central  Google Scholar 

  7. Van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2023;388:9–21. DOI: https://doi.org/10.1056/NEJMoa2212948

    Article  CAS  PubMed  Google Scholar 

  8. Jorfi M, Maaser-Hecker A, Tanzi RE. The neuroimmune axis of Alzheimer’s disease. Genome Med. 2023;15:6. DOI: https://doi.org/10.1186/s13073-023-01155-w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. De Strooper B, Karran E. The Cellular Phase of Alzheimer’s Disease. Cell. 2016;164:603–615. DOI: https://doi.org/10.1016/j.cell.2015.12.056

    Article  CAS  PubMed  Google Scholar 

  10. Bettcher BM, Tansey MG, Dorothée G, Heneka MT. Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat Rev Neurol. 2021;17:689–701. DOI: https://doi.org/10.1038/s41582-021-00549-x

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lange C, Aaby P, Behr MA, et al. 100 years of Mycobacterium bovis bacille Calmette-Guérin. Lancet Infect Dis. 2022;22:e2–e12. DOI: https://doi.org/10.1016/S1473-3099(21)00403-5

    Article  CAS  PubMed  Google Scholar 

  12. Lobo N, Brooks NA, Zlotta AR, et al. 100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19. Nat Rev Urol. 2021;18:611–622. DOI: https://doi.org/10.1038/s41585-021-00481-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ristori G, Romano S, Cannoni S, et al. Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS. Neurology. 2014;82:41–48. DOI: https://doi.org/10.1212/01.wnl.0000438216.93319.ab

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Weinberg MS, Zafar A, Magdamo C, et al. Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer. JAMA Netw Open. 2023;6:e2314336. DOI: https://doi.org/10.1001/jamanetworkopen.2023.14336

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wang E, Hagberg O, Malmström P-U. The association between BCG treatment in patients with bladder cancer and subsequent risk of develo** Alzheimer and other dementia.-A Swedish nationwide cohort study from 1997 to 2019. PLoS One. 2023;18:e0292174. DOI: https://doi.org/10.1371/journal.pone.0292174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gofrit ON, Klein BY, Cohen IR, Ben-Hur T, Greenblatt CL, Bercovier H. Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients. Ginsberg SD, editor. PLoS ONE. 2019;14:e0224433. DOI: https://doi.org/10.1371/journal.pone.0224433

    Article  CAS  Google Scholar 

  17. ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022: ORAL PRESENTATIONS. Pharmacoepidemiology and Drug. 2022;31:3–628. DOI: https://doi.org/10.1002/pds.5518

  18. Han C, Wang J, Chen Y-L, Guan C-P, Zhang Y-A, Wang M-S. The role of Bacillus Calmette-Guérin administration on the risk of dementia in bladder cancer patients: a systematic review and meta-analysis. Front Aging Neurosci. 2023;15:1243588. DOI: https://doi.org/10.3389/fnagi.2023.1243588

    Article  PubMed  PubMed Central  Google Scholar 

  19. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. DOI: https://doi.org/10.1136/bmj.n71

    Article  PubMed  PubMed Central  Google Scholar 

  20. ROBINS-E Development Group (Higgins J, Morgan R, Rooney A, Taylor K, Thayer K, Silva R, Lemeris C, Akl A, Arroyave W, Bateson T, Berkman N, Demers P, Forastiere F, Glenn B, Hróbjartsson A, Kirrane E, LaKind J, Luben T, Lunn R, McAleenan A, McGuinness L, Meerpohl J, Mehta S, Nachman R, Obbagy J, O’Connor A, Radke E, Savović J, Schubauer-Berigan M, Schwingl P, Schunemann H, Shea B, Steenland K, Stewart T, Straif K, Tilling K, Verbeek V, Vermeulen R, Viswanathan M, Zahm S, Sterne J). Risk Of Bias In Non-randomized Studies - of Exposure (ROBINS-E). Launch version, 20 June 2023. Available from: https://www.riskofbias.info/welcome/robins-e-tool.

  21. Veroniki AA, Jackson D, Viechtbauer W, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7:55–79. DOI: https://doi.org/10.1002/jrsm.1164

    Article  PubMed  Google Scholar 

  22. Makrakis D, Holt SK, Bernick C, Grivas P, Gore JL, Wright JL. Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer: Results From an Administrative Dataset. Alzheimer Dis Assoc Disord. 2022;36:307–311. DOI: https://doi.org/10.1097/wad.0000000000000530

    Article  PubMed  Google Scholar 

  23. Kim JI, Zhu D, Barry E, et al. Intravesical Bacillus Calmette-Guérin Treatment Is Inversely Associated With the Risk of Develo** Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2021;19:e409–e416. DOI: https://doi.org/10.1016/j.clgc.2021.05.001

    Article  PubMed  Google Scholar 

  24. Klinger D, Hill BL, Barda N, et al. Bladder Cancer Immunotherapy by BCG Is Associated with a Significantly Reduced Risk of Alzheimer’s Disease and Parkinson’s Disease. Vaccines (Basel). 2021;9:491. DOI: https://doi.org/10.3390/vaccines9050491

    Article  CAS  PubMed  Google Scholar 

  25. Tijms BM, Vromen EM, Mjaavatten O, et al. Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles. Nat Aging. Epub 2024 Jan 9. DOI: https://doi.org/10.1038/s43587-023-00550-7

  26. Bettcher BM, Tansey MG, Dorothée G, Heneka MT. Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat Rev Neurol. 2021;17:689–701. DOI: https://doi.org/10.1038/s41582-021-00549-x

    Article  PubMed  PubMed Central  Google Scholar 

  27. Taniguchi K, Koga S, Nishikido M, et al. Systemic immune response after intravesical instillation of bacille Calmette-Guérin (BCG) for superficial bladder cancer. Clin Exp Immunol. 1999;115:131–135. DOI: https://doi.org/10.1046/j.1365-2249.1999.00756.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Zuo Z, Qi F, Yang J, et al. Immunization with Bacillus Calmette-Guérin (BCG) alleviates neuroinflammation and cognitive deficits in APP/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain. Neurobiol Dis. 2017;101:27–39. DOI: https://doi.org/10.1016/j.nbd.2017.02.001

    Article  CAS  PubMed  Google Scholar 

  29. Li J, Zhan L, Qin C. The double-sided effects of Mycobacterium Bovis bacillus Calmette-Guérin vaccine. NPJ Vaccines. 2021;6:14. DOI: https://doi.org/10.1038/s41541-020-00278-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Li Y, Liu X, Wang W, et al. Low-dose IL-2 expands CD4+ regulatory T cells with a suppressive function in vitro via the STAT5-dependent pathway in patients with chronic kidney diseases. Ren Fail. 2018;40:280–288. DOI:10.1080/0886022X.2018.1456462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Baek H, Ye M, Kang G-H, et al. Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer’s disease model. Oncotarget. 2016;7:69347–69357. DOI: https://doi.org/10.18632/oncotarget.12469

    Article  PubMed  PubMed Central  Google Scholar 

  32. Keefe RC, Takahashi H, Tran L, et al. BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation. Sci Rep. 2021;11:14933. DOI: https://doi.org/10.1038/s41598-021-94529-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Dow CT, Greenblatt CL, Chan ED, Dow JF. Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer’s Disease. Microorganisms. 2022;10:424. DOI: https://doi.org/10.3390/microorganisms10020424

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zuo Z, Qi F, **ng Z, et al. Bacille Calmette-Guérin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP/PS1 mice following active amyloid-β immunotherapy. Neurobiol Aging. 2021;101:94–108. DOI: https://doi.org/10.1016/j.neurobiolaging.2021.01.001

    Article  CAS  PubMed  Google Scholar 

  35. Li Q, Wang X, Wang ZH, et al. Changes in dendritic complexity and spine morphology following BCG immunization in APP/PS1 mice. Hum Vaccin Immunother. 2022;18:2121568. DOI: https://doi.org/10.1080/21645515.2022.2121568

    Article  PubMed  PubMed Central  Google Scholar 

  36. Harrer, M., Cuijpers, P., Furukawa, T.A., & Ebert, D.D. (2021). Doing Meta-Analysis with R: A Hands-On Guide. Boca Raton, FL and London: Chapmann & Hall/CRC Press. ISBN 978-0-367-61007-4.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Wayne State University School of Medicine, 4201 St. Antoine, Detroit, Michigan, USA

    M. Ibrahim, P. Kim, R. Marawar & Konstantinos I. Avgerinos

Authors
  1. M. Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Marawar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Konstantinos I. Avgerinos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Konstantinos I. Avgerinos.

Ethics declarations

Conflict of Interest: On behalf of all authors, the corresponding author states that there is no conflict of interest.

Additional information

How to cite this article: M. Ibrahim, P. Kim, R. Marawar et al. Bacillus Calmette-Guerin (BCG) Vaccine Impact on Dementia Risk in Bladder Cancer Patients: A Systematic Review and Meta-analysis. J Prev Alz Dis 2024; https://doi.org/10.14283/jpad.2024.94

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ibrahim, M., Kim, P., Marawar, R. et al. Bacillus Calmette-Guerin (BCG) Vaccine Impact on Dementia Risk in Bladder Cancer Patients: A Systematic Review and Meta-Analysis. J Prev Alzheimers Dis (2024). https://doi.org/10.14283/jpad.2024.94

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.14283/jpad.2024.94

Key words

Search

Navigation